AVSF - Beacon Biosignals 2025, LLC — Form D
AVSF - Beacon Biosignals 2025, LLC of Boston, MA, a pooled investment fund, filed a Form D exempt-offering notice with the SEC on 2025-11-17. The offering totals $614K, of which $614K was reported sold. Industry: Pooled Investment Fund.
Offering
- Filed: 2025-11-17
- Form: D
- Accession: 0002095580-25-000001
- Industry: Pooled Investment Fund
- Exemptions: 06b, 3C, 3C.1
- Total offering: $614K
- Amount sold: $614K
- Minimum investment: $10K
- Investors: 26
- Date of first sale: 2025-11-01
- Security types: equity, fund interests
- Revenue range: $1 - $1,000,000
- SEC file number: 021-564227
Issuer
- Name: AVSF - Beacon Biosignals 2025, LLC
- CIK: 0002095580
- Entity type: Limited Liability Company
- Jurisdiction: DELAWARE
- Incorporated: 2025
- Address: 70 Federal Street, Boston, MA, 02110
- Phone: 603-518-8112
Officers, directors & promoters (1)
| Name | Role | Location |
|---|
| Michael Collins | Executive Officer | Del Mar, CA |
More